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AbstrACt
Introduction Pre-eclampsia is a common disorder 
associated with serious maternal and fetal complications. 
It is associated with abnormal placentation, which 
significantly reduces flow, resulting in a relative hypoxic 
state. These pathophysiological changes lead to subtle 
macrovascular and cardiac structural and functional 
changes in the fetus. This can predispose the child with 
maternal history of pre-eclampsia to risk of premature 
cardiovascular disease.
Methods and analysis The children will be identified 
from a cohort of women with pre-eclampsia. The study will 
be conducted at The Aga Khan University Hospital, Karachi. 
Inclusion criteria will be children who are between 2 and 5 
years of age and have a maternal history of pre-eclampsia. 
The child’s current weight, height and blood pressure will 
be recorded. A two-dimensional functional echocardiogram 
and vascular assessment will be performed to evaluate 
alterations in cardiac function as well as macrovascular 
remodelling in these children. Data will be presented as 
mean±SD, median (IQR) or percentages as appropriate. 
Independent t-test or Mann-Whitney U test will be used for 
testing of continuous variables (based on the assumption 
of normality). A p<0.05 will be used to determine statistical 
significance.
Ethics and dissemination Ethical approval has been 
obtained from AKUH Ethics Review Committee. Findings 
will be disseminated through scientific publications and 
project summaries for the participants.
IntroduCtIon  
Pre-eclampsia is a pregnancy-specific condi-
tion, defined by the sudden onset of hyper-
tension (systolic blood pressure (BP) of 
>140 mm Hg and diastolic BP of >90 mm 
Hg, taken on two separate occasions at least 
4–6 hours apart) and significant proteinuria 
(excretion of 300 mg or more of protein every 
24 hours) after the 20th week of gestation.1 
Hypertensive disorders of pregnancy account 
for 9% of maternal deaths in Asia and Africa. 
This translates into approximately 25 000 
maternal deaths in low/middle-income coun-
tries such as Asia and Africa as compared with 
only 150 maternal deaths in the industrialised 
world.2 This number may actually be higher 
once the revised American College of Obste-
tricians and Gynecologists guidelines on diag-
nosis of pre-eclampsia without proteinuria 
are incorporated.3 
Pre-eclampsia may result in the development 
of recognised cardiovascular disease (CVD) 
risk factors in the offspring. A recent system-
atic review on CVD risk in children between 
the ages of 4 and 19 years stated that systolic 
BP was higher in children born to pre-ec-
lamptic mothers as compared with controls 
(mean difference=2.26 mm Hg, 95% CI 
1.35 to 3.16), but this effect was not seen in 
diastolic BPs (mean difference=1.48 mm Hg), 
95% CI 0.82 to 2.14.4 It was also reported that 
children with a mean birth weight of >2.5 kg 
with history of exposure to pre-eclampsia in 
utero, had a significantly increased body mass 
index (BMI) (0.67 kg/m2; 95% CI 0.35 to 
0.99; p=0.0001) as compared with controls.4 
These studies were limited by a lack of assess-
ment of cardiac and vascular remodelling, 
alterations of which could have been present 
in this population predisposing the child to 
future CVD risk.
There are very few studies that have looked 
at cardiac function using echocardiography 
(ECHO) in children of pre-eclamptic mothers. 
CHASE study (cardiovascular health after 
pregnancy complications) conducted in chil-
dren between the ages of 5 and 8 years born to 
strengths and limitations of this study
 ► This is one of the first studies to objectively assess 
cardiovascular risk in children (aged 2–5 years) born 
to pre-eclamptic mothers, including early-onset and 
late-onset pre-eclampsia.
 ► The aims of this study are supported by objective 
echocardiographic and vascular data.
 ► The current protocol does not include microvascular 
assessment.
 ► The cohort not controlled for management and out-
come of pre-eclampsia.
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mothers suffering from pre-eclampsia reported that these 
children had a shorter left ventricular (LV) end-diastolic 
length and increased late diastolic velocity (A’ wave) that 
may be an indicator of diastolic dysfunction.5 However, the 
sample size of this study was very small (n=25) and thus 
probably inadequately powered for any conclusive results.
There is limited literature on vascular function in chil-
dren born to pre-eclamptic mothers. Aortic intima–media 
thickness (IMT) was significantly higher in neonates of 
mothers with pre-eclampsia (mean—0.36±0.03 mm) as 
compared with controls (mean—0.33±0.03 mm).6 This 
study was conducted in neonates and hence the effect 
of pre-eclampsia exposure later in childhood remained 
unexplored.
The clinical expression of pre-eclampsia can be further 
reclassified based on early-onset versus late-onset disease; 
early pre-eclampsia refers to the disease presenting at <34 
weeks of gestation while late pre-eclampsia refers to mani-
festations >34 weeks.7 Lazdam et al have reported that 
children born to mothers with early-onset pre-eclampsia 
have significantly higher systolic BPs (96.3±7.3 mm Hg) 
between 6 and 13 years of age as compared with those 
who were born to mothers with late onset of the disease 
(88.4±7.6 mm Hg).8 Despite this preliminary evidence, 
there is lack of literature on cardiac and vascular function 
in these subgroups.
The primary objective of this study is to do a detailed 
cardiovascular assessment by differences in BP, myocardial 
systolic, diastolic function, regional and global myocardial 
strain as well as changes in carotid IMT (cIMT) and pulse 
wave velocity (PWV) in children 2–5 years of age born to 
pre-eclamptic as compared with normotensive mothers. 
The secondary objective of this study is to assess cardiac 
and vascular function in children 2–5 years of age born to 
early versus late pre-eclamptic mothers.
MEthods And AnAlysIs
setting
The study will be conducted at The Aga Khan University 
Hospital (AKUH), Karachi, Pakistan.
design
This will be a prospective cohort study design with the 
exposure status of the child (ie, pre-eclampsia) being 
identified from maternal records at AKUH. All echo-
cardiographic and vascular assessments to determine 
the cardiovascular risk of the exposed cohort will be 
performed during the course of the study. No such data 
are available in medical records. The study recruitment 
will be over an 18-month period.
Inclusion and exclusion criteria
The inclusion criteria for exposed group are children 
between 2 and 5 years of age at the time of enrolment 
in the study with history of pre-eclampsia in the mother 
during pregnancy as diagnosed by the obstetrician. The 
inclusion criteria for non-exposed group are children 
between 2 and 5 years of age born to mothers with a 
normal BP. The exclusion criteria for both groups are 
presence of maternal comorbids such as gestational 
hypertension, diabetes, maternal obesity (BMI >25 kg/
m2), hypothyroidism; chromosomal abnormalities and 
congenital heart disease. Inability to acquire all echocar-
diographic and at least one cIMT image, will also lead to 
exclusion of that patient from the analysis.
sample size calculation
Differences in ratio of pulse wave Doppler (PWD) derived 
early diastolic filling velocity of left ventricle (E) to tissue 
Doppler imaging (TDI) derived early diastolic myocar-
dial velocity (E’) acquired at the base of the ventricular 
septum and TDI derived peak systolic myocardial velocity 
of the right ventricle(S’ in cm/s) were used to calculate 
sample size as they have a high sensitivity to detect preclin-
ical cardiac dysfunction in children.9 The sample size 
was calculated using WHO sample size calculator V.2.0 
with 90% statistical power and using 5% level of signifi-
cance. Published data of mean pulsed wave E’ obtained 
in pre-eclamptic children (2.18±0.33 mm/s) and controls 
(2.02±0.31 mm/s) was used.5 Based on this data, a sample 
size of 80 in each group was calculated. A sample size of 
22 in each group was calculated using similar assump-
tions for cIMT along with published data in pre-eclamptic 
children (0.36±0.03 mm) and controls (0.33±0.03 mm).6 
Based on these, we will recruit 80 children born to 
pre-eclamptic mothers and controls, respectively, with a 
minimum of 20 children in each of the early-onset versus 
late-onset disease group.
recruitment procedure
Data for children who meet the inclusion criteria will be 
obtained from AKUH’s Hospital Information Manage-
ment System. Parents of these children would then be 
called by a trained data collector and briefed regarding the 
purpose of the study. For those who agree on the follow-up 
call, appointment for a two-dimensional functional echo-
cardiographic study and vascular imaging of the child will 
be scheduled with a paediatric cardiologist in the morning.
The child’s height, weight and BP will be recorded at 
the ECHO laboratory at AKUH. A focused ECHO will 
then be performed by a trained technician to assess 
cardiac function as well as cIMT and PWV. The procedure 
will take 15–20 min for each participant. All studies will 
be reviewed by two independent paediatric cardiologists 
(BSH and DC) who will be blinded to the patient expo-
sure group. The findings of the echocardiogram will be 
shared with the parents after the ECHO is complete.
Measures of outcomes
Anthropometry
Weight and height of the child will be recorded using 
a weighing scale with a stadiometer (Detecto Scales 
WS#149).
BP measurement
Resting BP of the child in right upper extremity will be 
recorded manually 3–5 min apart. BP will be measured 
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manually with a sphygmomanometer with the appro-
priate cuff size. The average reading would be compared 
with the z scores available on a free software.10
Echocardiographic examination
All echocardiographic examinations will be performed 
using the GE Healthcare Vivid E9 (GE Healthcare, 
Waukesha, Wisconsin, USA) using 5–12 MHz phased 
array transducers. All cardiac parameters will be measured 
over three consecutive cardiac cycles and the average 
reading will be reported. The following parameters will 
be analysed:
Cardiac morphometry
This includes left atrium (LA) area, LV mass, sphericity 
index and relative wall thickness. LA area will be traced 
in the apical four-chamber view of the heart. Semiau-
tomated tracing of the LA endocardium will then be 
performed to obtain LA area. These will be indexed to 
body surface area.11 LV mass will be assessed using the 5/6 
X area X length method12 and z scores will be obtained. 
Linear measurements of base-to-apex length and basal 
diameter of left and right ventricles will be determined 
from an apical four-chamber view at end diastole. Sphe-
ricity index (base to apex length/basal diameter of the 
ventricle) for both the ventricles will then be calculated13 
(refer to figure 1). LV end-diastolic septal and posterior 
wall thicknesses will be measured in parasternal short axis 
view. Relative wall thickness will be calculated as posterior 
+septal wall thickness/LV end-diastolic diameter14 (refer 
to figure 2).
Systolic function
Measurements for LV includes ejection fraction, short-
ening fraction (SF), stroke volume, heart rate, cardiac 
outputs (measured in parasternal long and short axis 
view) (assessed using the 5/6 X area X length method) 
and mitral annular plane systolic excursion (measured 
by M-mode in apical four-chamber view).15 Velocity of 
circumferential fibre contraction (VCFc) is a preload-in-
dependent measure of LV function and is inversely 
related to end-systolic wall stress (ESWS).16 The VCFc to 
ESWS relation is a preload independent, afterload incor-
porated function of contractility.16 It is calculated using 
the formula SF/heart rate adjusted ejection time. For 
SF, we will be using the formula end-diastolic diameter 
− end-systolic diameter/end-diastolic diameter. ESWS 
will be calculated by using Grossman’s formula (1.35 
(LV end-systolic pressure) (LV internal diameter)/4(pos-
terior wall thickness at end systole) (1 + (posterior wall 
thickness at end systole/LV internal diameter). We will 
be calculating mean arterial pressure using the formula 
1/3 systolic BP +2/3 diastolic BP as a surrogate for LV 
end-systolic pressure. These diameters will be assessed in 
parasternal short axis view.16
For the right ventricle, measurements include tricuspid 
annular plane systolic excursion measured by M-mode, 
systolic annular peak velocities (S’) using TDI15 and frac-
tional area of change obtained by ((end-diastolic area − 
end-systolic area)/end-diastolic area).15
Diastolic function
Using PWD, mitral inflow peak early filling (E’) and peak 
atrial filling (A’) wave velocities will be measured using 
the apical four-chamber view, and the E/A ratio calcu-
lated. Deceleration time will be measured as the time 
between the peak E velocity and the point where the 
velocity returns to zero. TDI derived peak early (E’) and 
peak late (A’) diastolic velocities will also be measured at 
the base of the interventricular septum. All these values 
will be derived from three consecutive cardiac cycles and 
Figure 1 Measurement of sphericity index (in apical four-
chamber view) (base to apex length/basal diameter of the 
ventricle).
Figure 2 Global longitudinal strain from two, three and four-
chamber view and bull’s eye measurement of regional strain.
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averaged. The E-wave to LV E’ velocity ratio (E/E’) will 
then be calculated.15
Global function
The myocardial performance index (Tei index) has 
been used to assess combined LV systolic and diastolic 
function. It is calculated as isovolumic contraction time 
plus isovolumic relaxation time divided by ejection time. 
These timings will be reported separately and also as a 
collection function in the form of Tei Index value. Each 
value is recorded over three consecutive beats and aver-
aged out for calculation of the index. It is measured by a 
PWD positioned at the tip of mitral leaflets in the apical 
five-chamber view.15
Strain analysis
Using the GE Healthcare Vivid E9 ultrasound system, 
digital loops with three consecutive cardiac cycles will be 
acquired from apical two, three and four-chamber view, 
with frame rate set at more than 60 frames/s(frame rate 
to heart rate ratio of close to 1). Strain analysis, via speckle 
tracking, will be performed directly on the system for each 
of the three apical views. The operator will manually iden-
tify 2 points on each side of the mitral valve and 1 point 
at the LV apex. Using the Automated Functional Imaging 
(AFI) strain technique, the software automatically detects 
the endocardium and tracks the myocardium during the 
entire cardiac cycle (refer to figure 2).17 Global longi-
tudinal strain and will then be calculated by averaging 
the 16 segment strains of the LV. Peak global longitu-
dinal strain rate, peak early diastolic filling and peak late 
diastolic filling strain rates will also be reported. Tracking 
quality will be assessed by the observer and endocardial 
tracing will be readjusted or the imaging repeated if the 
quality is unsatisfactory.17 Images with at least four out 
of six segments deemed to be adequately tracked by the 
automated system will be selected for analysis. The AFI 
technique determines aortic valve closure from the three-
chamber view while the strain analysis begins from the 
peak of the R-wave on ECG.
Global and regional strain longitudinal will also be 
calculated from only the four-chamber view. Aortic valve 
opening and closure will be determined using PWD across 
the aortic valve with a similar R-R interval on ECG.18 LV 
endocardium will then be traced and tracking assessed 
manually. Image will be selected if at least four segments 
out of the six are considered to be adequately tracked. In 
this technique, strain analysis will be measured from the 
beginning of the R-wave on ECG.
Vascular examination
Carotid intima–media thickness
The examination will be performed using the Association 
for European Paediatric Cardiology Working Group on 
Cardiovascular Prevention guidelines.19 The GE Health-
care Vivid E9 ultrasound scanner with a 7–12 MHz linear 
transducer will be used to acquire the images. The subject 
will be placed supine in a quiet room with the head 
extended and turned away from the transducer. Longi-
tudinal images of the common carotid artery both sides 
will be obtained proximal to the carotid bulb. Minimum 
5 s clip will be recorded and stored for each vessel to 
allow selection of the most appropriate frame for offline 
analysis.19 cIMT measurements will be taken from the far 
wall of the common carotid artery, 10 mm away from the 
carotid bulb. On the carotid wall, two bright lines sepa-
rated by a darker area will be identified (refer to figure 3). 
The IMT software will then be used to delineate 105–110 
points on a pixel basis and the average cIMT value (over 
three consecutive heart cycles) will be calculated for each 
side.
Pulse wave velocity
Carotid femoral PWV is calculated by dividing distance 
travelled by the transit time.20 The study participant will 
be laid supine with the head extended. The right carotid 
and right femoral artery will be felt manually and PWD 
will be obtained on each. The distance will be measured 
by direct distance of common carotid artery to femoral 
artery pulse multiplied by 0.8. The transit time will be 
indirectly obtained by subtracting the time delay between 
the onset of R wave and upstroke of common carotid 
artery and onset of R wave and upstroke of common 
femoral artery.20 The measurements will be performed 
offline on DICOM raw data on ECHOPAC software to 
preserve the frame rate at which the image was acquired 
(refer to figure 4).
Patient and public involvement
Patients and the public were not involved in the design of 
this study. However, all study participants will be informed 
regarding the study findings via email after the study 
results are published.
statistical analysis plan
Data will be entered and analysed using SPSS V.19.0. 
Data will be presented as mean±SD, median (IQR) or 
Figure 3 Intima–media thickness of common carotid artery.
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percentages as appropriate. Cardiac measurements will be 
standardised using appropriate z scores on a software that 
is freely available on the internet.10 Independent t-test or 
Mann-Whitney U test will be used for testing of contin-
uous variables (based on the assumption of normality). 
Variables with a p<0.1 or those that are clinically relevant 
will be used for the multivariable model (one assump-
tions are fulfilled). Multivariate analysis will control for 
confounders such as maternal BMI, birth weight, gesta-
tional age, child’s BMI and heart rate. A p<0.05 will be 
used to determine statistical significance.
Two independent observers will perform IMT and global 
longitudinal strain calculations on 20 studies as well to 
determine interobserver variability. Bland-Altman graphs 
will be generated to determine the interobserver variability.
EthICs And dIssEMInAtIon
Findings of this study will be disseminated by means of 
scientific publications and continuous medical educa-
tion seminars. The study participants will be informed 
regarding the study findings through project summaries 
and sharing of key findings.
study stAtus
We plan to begin enrolment in July 2018.
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